PRNewswire New Delhi [India]1 Translumina was incorporated in 2011 as a sales marketing company specialising in coronary ...

Translumina, established in 2011, focuses on coronary intervention devices and has expanded its manufacturing capabilities and product lines. The company aims to highlight Indian innovation in the ...

A study has found that sirolimus-coated balloons vs thin drug-eluting stents in in-stent restenosis show similar favorable clinical outcomes.

The vascular stents market is anticipated to grow from USD 11.4 billion in 2024 to USD 15.6 billion by 2029, with a CAGR of 6.5%. This growth is driven by increasing cases of vascular diseases and a ...

Using optimal coherence tomography (OCT) to guide stent implantation during percutaneous coronary intervention (PCI) in ...

Undergoing percutaneous coronary intervention (PCI) for narrowed arteries with a novel bioadaptor is at least as effective as ...

The DynamX Bioadaptor device was noninferior to DES for TLF overall, but a landmark analysis reveals a potential strength.

The trial was set up to give DCBs their “best shot” in this patient group, says one researcher, but it’s tough to beat current DES.

Balloon angioplasty plus medical management offered better outcomes in patients with symptomatic intracranial atherosclerotic ...

Millions of people who take a cholesterol-lowering drug may be suffering from amnesia without realising it, scientists believe. Statins, which are taken by people at risk of heart disease ...